Search

Your search keyword '"Su, Qing"' showing total 263 results
Start Over Author "Su, Qing" Publication Year Range Last 50 years Publisher elsevier b.v.
263 results on '"Su, Qing"'

12. Clinical expert consensus on the assessment and protection of pancreatic islet β-cell function in type 2 diabetes mellitus

Author

Zhu, Jian, Han, Junfeng, Liu, Liehua, Liu, Yu, Xu, Wen, Li, Xiaomu, Yang, Lin, Gu, Yong, Tang, Wei, Shi, Yongquan, Ye, Shandong, Hua, Fei, Xiang, Guangda, Liu, Ming, Sun, Zilin, Su, Qing, Li, Xiaoying, Li, Yuxiu, Li, Yanbing, Li, Hong, Li, Yiming, Yang, Tao, Yang, Jing, Shi, Lixin, Yu, Xuefeng, Chen, Li, Shao, Jiaqing, Liang, Jun, Han, Xiao, Xue, Yaomin, Ma, Jianhua, Zhu, Dalong, and Mu, Yiming

Published
2023
Full Text
View/download PDF

22. Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP)

Author

Ji, Linong, Song, Weihong, Fang, Hui, Li, Wei, Geng, Jianlin, Wang, Yangang, Guo, Lian, Cai, Hanqing, Yang, Tao, Li, Hongmei, Yang, Gangyi, Li, Qifu, Liu, Kuanzhi, Li, Shuying, Liu, Yanjun, Shi, Fuyan, Li, Xinsheng, Gao, Xin, Tian, Haoming, Ji, Qiuhe, Su, Qing, Zhou, Zhiguang, Wang, Wenbo, Zhou, Zunhai, Li, Xuejun, Xu, Yancheng, Ning, Zhiqiang, Cao, Haixiang, Pan, Desi, Yao, He, Lu, Xianping, and Jia, Weiping

Published
2021
Full Text
View/download PDF

27. Characteristics of metabolic inflammatory syndrome among inpatients with type 2 diabetes: A cross-sectional study in China.

Author

Li, Rumei, Lu, Bin, Li, Qiang, Hu, Ji, Huang, Yun, Wang, Yangang, Qin, Guijun, Zhang, Weiwei, Su, Qing, Zhu, Jun, Xu, Yancheng, Jiang, Hongwei, Wang, Xinjun, Zhang, Keqing, Yang, Yuzhi, and Hu, Renming

Abstract

As meta-inflammation is a common feature for obesity, type 2 diabetes (T2D), nonalcoholic fatty liver disease and atherosclerosis, we have proposed a new concept, metabolic inflammatory syndrome (MIS), to cluster such diseases. We aimed to characterize MIS and explore its association with coronary heart disease (CHD) among T2D inpatients in China. A total number of 8344 T2D participants were enrolled. Each component of MIS and metabolic syndrome (MS) was analyzed. Their association with the risk of CHD was assessed using a binary logistic analysis. Among the T2D inpatients, the detection rate of MIS was much higher than that of MS (93.6 % vs. 53.2 %). Among all the components of MIS and MS, carotid atherosclerosis (71.9 %) was most commonly detected, which increased with aging in subgroups. Surprisingly, the most common combination of MIS was with all 4 components in T2D patients, with a constituent ratio of 30.9 %. According to the odds ratios (ORs), MIS was a better predictor of CHD than MS, especially after adjustment for age, sex, smoking, and alcohol consumption (adjusted OR for MIS: 3.083; for MS: 1.515). The presence of more components of MIS was associated with a higher detection rate of CHD (P < 0.001). Among all the components of MIS and MS, carotid atherosclerosis best predicted the risk of CHD (adjusted OR: 1.787). MIS is an independent risk factor for CHD, with a bigger OR value than MS. Carotid atherosclerosis, with the highest detection rate, was the best individual predictor of CHD and thus a critical component of MIS. The concept of MIS represents the understanding of metabolic diseases from the perspective of holistic integrative medicine. • Metabolic Inflammatory Syndrome (MIS) is an independent risk factor for coronary heart disease. • Among all the components of MIS, atherosclerosis was the best predictor of coronary heart disease and a critical component of MIS. • The concept of MIS represents the understanding of metabolic diseases from the perspective of holistic integrative medicine. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results